Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 59Terminated 23Unknown 15Recruiting 10Withdrawn 4Not yet recruiting 3Enrolling by invitation 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 4Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 8Anemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 7Myelodysplastic Syndromes 7Primary Myelofibrosis 5Myeloproliferative Disorders 5Lymphoma, Follicular 5Leukemia 5Hematologic Neoplasms 5Anemia, Refractory, with Excess of Blasts 5Thrombocytopenia 4Polycythemia Vera 4Lymphoma, Mantle-Cell 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Febrile Neutropenia 4Congenital Abnormalities 4Anemia, Sickle Cell 4Anemia, Aplastic 4Thrombocythemia, Essential 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia, Neutrophilic, Chronic 3Leukemia, Myelomonocytic, Chronic 3Burkitt Lymphoma 3Blast Crisis 3

Interventions

siltuximab 1avatrombopag 1Transplantation 1Pluvicto 1Peripheral Blood Stem Cell Transplantation 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Thrombocytopenia × Classical hematology × Clear all
NCT07025512 2026-05-08

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Classical hematology

Cytopenia, Anemia, Thrombocytopenia

NCT01660347 2025-05-02

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Thomas Jefferson University

Phase NA Withdrawn
Classical hematologyOther hematologic neoplasm

Anemia, Lymphopenia, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT04437953 2020-12-08

Avatrombopag for Thrombocytopenia in People With Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn
Classical hematology

Liver Diseases, Neoplasms, Thrombocytopenia

NCT02805868 2016-10-24

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Northwestern University

Phase EARLY_PHASE1 Withdrawn
Classical hematologyLymphoidMyeloid

Anemia, Lymphoma, Follicular, Polycythemia Vera, Thrombocytopenia, Thrombocytosis, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡